drugset / Trial / NCT05767086

Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles

NCT05767086

Completed 297 enrolled Bezmialem Vakif University
RandomizedParallel-groupOpen-labelPrevention

Summary

The aim of study is to evaluate the results of three different protocols for prevention of premature ovulation in ovarian stimulation cycles. All patients that undergo IVF cycles are randomly divided into three groups. The first group is cetrorelix, the second group is medroxyprogesterone acetate and the third group is dydrogesterone.

Timeline

Start
2023-03-15
Primary completion
2024-09-30
Completion
2024-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cetrorelix Other / unclassified 0.25 mg Subcutaneous
Subject Dydrogesterone Other / unclassified 10 mg Oral
Subject medroxyprogesterone acetate Other / unclassified 5 mg Oral

Indications